Diabetes mellitus therapies aim to reduce disease complications, such as nephropathy, by achieving long-term blood glucose regulation, but actually doing so is difficult. A recent study by Sacramento and colleagues has applied electronic modulation of nerve activity in rodents as an approach to treat diabetes mellitus.
S.A.S. is supported by NIH (MH105941 and 1R01NS097184), American Diabetes Association (ADA #1-17-ACE-31), Einstein-Mt. Sinai Diabetes Research Center Pilot and Feasibility award (P30DK020541) and Alexander and Alexandrine Sinsheimer Scholar Award.